The identification of high-performing antibodies for TDP-43 for use in Western Blot, immunoprecipitation and immunofluorescence
F1000Research · 20.06.2023 · 12 · 277
DOI: 10.12688/f1000research.131852.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift F1000Research, online erschienen am 20.06.2023. Verfasst von Donovan Worrall und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Quebec, H…. Hauptthemen laut MEDLINE: DNA-Binding Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Motor Neurone Disease Association, Mitacs, ALS Association.
Abstract (Originalsprache)
TAR DNA-binding protein 43 (TDP-43) is a DNA/RNA binding protein playing a critical role in the regulation of transcription, splicing and RNA stability. Mutations in TARDBP leading to aggregation, are suspected to be a characteristic feature of various neurogenerative diseases. The lack of well-characterized anti- TDP-43 antibodies acts as a barrier to establish reproducible TDP-43 research. In this study, we characterized eighteen TDP-43 commercial antibodies for Western blot, immunoprecipitation, and immunofluorescence using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. We identified many well-performing antibodies and encourage readers to use this report as a guide to select the most appropriate antibody for their specific needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Quebec, H3A 2B4, Canada.
ORCID-Profile: Donovan Worrall, Kathleen Southern, Carl Laflamme
Förderung
- Motor Neurone Disease Association
- Mitacs
- ALS Association
- Genome Canada
- ALS Society of Canada
- Canadian Institutes of Health Research Foundation
- Ontario Genomics
- Genome Quebec
Zitieren
APA
Worrall, D., Ayoubi, R., Fotouhi, M., Southern, K., McPherson, P. S., Laflamme, C., NeuroSGC/YCharOS/EDDU collaborative group, & ABIF Consortium (2023). The identification of high-performing antibodies for TDP-43 for use in Western Blot, immunoprecipitation and immunofluorescence. F1000Research, 12, 277. https://doi.org/10.12688/f1000research.131852.2
Vancouver
Worrall D, Ayoubi R, Fotouhi M, Southern K, McPherson PS, Laflamme C, et al. The identification of high-performing antibodies for TDP-43 for use in Western Blot, immunoprecipitation and immunofluorescence. F1000Research. 2023;12:277. doi:10.12688/f1000research.131852.2
BibTeX
@article{Worrall2023,
author = {Worrall, Donovan and Ayoubi, Riham and Fotouhi, Maryam and Southern, Kathleen and McPherson, Peter S and Laflamme, Carl and NeuroSGC/YCharOS/EDDU collaborative group, NeuroSGC/YCharOS/EDDU collaborative group and ABIF Consortium, ABIF Consortium},
title = {The identification of high-performing antibodies for TDP-43 for use in Western Blot, immunoprecipitation and immunofluorescence},
journal = {F1000Research},
year = {2023},
volume = {12},
pages = {277},
doi = {10.12688/f1000research.131852.2}
}
EUVIMED